Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study
- 1 April 2001
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 40 (1-2) , 51-57
- https://doi.org/10.1016/s0732-8893(01)00241-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A Comparative In Vitro Surveillance Study of Gemifloxacin Activities against 2,632 Recent Streptococcus pneumoniae Isolates from across Europe, North America, and South AmericaAntimicrobial Agents and Chemotherapy, 2000
- Benchmarking the in vitro activity of moxifloxacin against recent isolates of Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae. A European multi-centre studyDiagnostic Microbiology and Infectious Disease, 2000
- Antimicrobial activity of advanced-spectrum fluoroquinolones tested against more than 2000 contemporary bacterial isolates of species causing community-acquired respiratory tract infections in the United States (1999)Diagnostic Microbiology and Infectious Disease, 2000
- Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methodsJournal of Antimicrobial Chemotherapy, 2000
- In Vitro Susceptibility to Gemifloxacin and Trovafloxacin of Streptococcus pneumoniae Strains Exhibiting Decreased Susceptibility to CiprofloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 2000
- Comparative In Vitro Activities of Ciprofloxacin, Gemifloxacin, Grepafloxacin, Moxifloxacin, Ofloxacin, Sparfloxacin, Trovafloxacin, and Other Antimicrobial Agents against Bloodstream Isolates of Gram-Positive CocciAntimicrobial Agents and Chemotherapy, 2000
- Antipneumococcal Activities of Gemifloxacin Compared to Those of Nine Other AgentsAntimicrobial Agents and Chemotherapy, 2000
- Activity of Gemifloxacin against Penicillin- and Ciprofloxacin-Resistant Streptococcus pneumoniae Displaying Topoisomerase- and Efflux-Mediated Resistance MechanismsAntimicrobial Agents and Chemotherapy, 1999
- Decreased Susceptibility ofStreptococcus pneumoniaeto Fluoroquinolones in CanadaNew England Journal of Medicine, 1999
- Anti-streptococcal activity of SB-265805 (LB20304), a novel fluoronaphthyridone, compared with five other compounds, including quality control guidelinesDiagnostic Microbiology and Infectious Disease, 1999